Amidation of salicyluric acid and gentisuric acid:: A possible role for peptidylglycine α-amidating monooxygenase in the metabolism of aspirin

被引:17
作者
DeBlassio, JL
deLong, MA
Glufke, U
Kulathila, R
Merkler, KA
Vederas, JC
Merkler, DJ [1 ]
机构
[1] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
[2] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA
[3] Procter & Gamble Co, Corp Ctr, Miami Valley Labs, Cincinnati, OH 45040 USA
[4] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada
[5] Novartis Pharmaceut Inc, Xray Crystallog Dept, Summit, NJ USA
关键词
aspirin metabolism; salicyluric acid; gentisuric acid; peptidylglycine alpha-amidating monooxygenase; novel substrates for;
D O I
10.1006/abbi.2000.2047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bifunctional peptidylglycine alpha -amidating monooxygenase (PARI) catalyzes the copper-, ascorbate-, and O-2-dependent cleavage of C-terminal glycine-extended peptides, N-acylglycines, and the bile acid glycine conjugates to the corresponding amides and glyoxylate, Two known metabolites of aspirin, salicyluric acid and gentisuric acid, are also substrates for PAM, leading to the formation of salicylamide and gentisamide. The time course for O-2 consumption and glyoxylate production indicates that salicylurate amidation is a two-step reaction. Salicylurate is first converted to N-salicyl-alpha -hydroxyglycine, which is ultimately dealkylated to salicylamide and glyoxylate. The enzymatically generated salicylamide and N-salicyl-alpha -hydroxyglycine were characterized by mass spectrometry and two-dimensional H-1-C-13 heteronuclear multiple quantum coherence NMR. (C) 2000 Academic Press.
引用
收藏
页码:46 / 55
页数:10
相关论文
共 57 条
  • [1] THE INFLUENCE OF AGE ON SALICYLATE PHARMACOKINETICS IN HUMANS
    ABDALLAH, HY
    MAYERSOHN, M
    CONRAD, KA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 380 - 387
  • [2] IDENTIFICATION OF FATTY-ACID AMIDES IN HUMAN-PLASMA
    ARAFAT, ES
    TRIMBLE, JW
    ANDERSEN, RN
    DASS, C
    DESIDERIO, DM
    [J]. LIFE SCIENCES, 1989, 45 (18) : 1679 - 1687
  • [3] ASAOKA K, 1991, INT J BIOCHEM, V23, P429, DOI 10.1016/0020-711X(91)90170-R
  • [4] BENNETT M J, 1991, Pediatric Pathology, V11, P889
  • [5] SALICYLATE METABOLITE KINETICS AFTER SEVERAL SALICYLATES
    BOCHNER, F
    GRAHAM, GG
    CHAM, BE
    IMHOFF, DM
    HAAVISTO, TM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 266 - 275
  • [6] Peptidylglycine α-amidating mono-oxygenase:: Neuropeptide amidation as a target for drug design
    Bolkenius, FN
    Ganzhorn, AJ
    [J]. GENERAL PHARMACOLOGY, 1998, 31 (05): : 655 - 659
  • [7] TISSUE SPECIFIC EXPRESSION OF RAT PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE ACTIVITY AND MESSENGER-RNA
    BRAAS, KM
    STOFFERS, DA
    EIPPER, BA
    MAY, V
    [J]. MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) : 1387 - 1398
  • [8] INTERRELATIONSHIPS OF LIVER AND BRAIN WITH SPECIAL REFERENCE TO REYE SYNDROME
    BROWN, JK
    IMAM, H
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (04) : 436 - 458
  • [9] CHAM BE, 1979, CLIN CHEM, V25, P1420
  • [10] QUANTITATIVE ESTIMATION OF SALICYLIC-ACID AND ITS METABOLITES BY THIN-LAYER DENSITOMETRY
    CHRASTIL, J
    WILSON, JT
    [J]. JOURNAL OF CHROMATOGRAPHY, 1978, 152 (01): : 183 - 189